Literature DB >> 19862941

Itraconazole, an effective adjunctive treatment for allergic bronchopulmonary aspergillosis.

A Santos1, G Loureiro, E Faria, C Chieira.   

Abstract

We report the case of a 21-year old man with a long-standing history of severe asthma and allergic rhinosinusitis who developed progressive worsening of dyspnea, wheezing, productive cough, and nasal obstruction, with little response to antibiotics and repeated short courses of oral corticosteroids. A diagnosis of allergic bronchopulmonary aspergillosis was made on the basis of a combination of clinical, laboratory and radiographic findings.Treatment with oral methylprednisolone and itraconazole resulted in an improvement in symptoms, lung function and computed tomography results, as well as in a decrease in total serum immunoglobulin E. This case report highlights the importance of a high degree of clinical suspicion in order to diagnose and treat allergic bronchopulmonary aspergillosis in patients with a long-standing history of severe asthma as early as possible as this has a major impact on prognosis. It also highlights the effectiveness of itraconazole as adjunctive therapy to systemic corticosteroids in this condition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19862941

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  2 in total

1.  Case of seropositive allergic bronchopulmonary aspergillosis in a 10-year-old girl without previously documented asthma.

Authors:  Jeong Eun Shin; Jae Won Shim; Deok Soo Kim; Hae Lim Jung; Moon Soo Park; Jung Yeon Shim
Journal:  Korean J Pediatr       Date:  2015-05-22

2.  Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the Literature.

Authors:  Samantha E Jacobs; Deborah Saez-Lacy; Walter Wynkoop; Thomas J Walsh
Journal:  Open Forum Infect Dis       Date:  2017-05-05       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.